Zoromol-SP Tablet

Serratiopeptidase, a proteolytic enzyme, facilitates the breakdown of inflammatory mediators and promotes the resolution of inflammation and edema, enhancing tissue repair and reducing pain. This combination is indicated for the management of acute and chronic musculoskeletal disorders, postoperative pain, rheumatoid arthritis, osteoarthritis, and other inflammatory conditions where pain and swelling are prominent.

Zoromol-SP offers rapid and sustained relief from pain and inflammation, improving patient mobility and quality of life. It should be used under medical supervision, with caution in patients with a history of gastrointestinal ulcers, bleeding disorders, or hepatic and renal impairment. Common adverse effects may include gastrointestinal discomfort, nausea, and hypersensitivity reactions.

Regular monitoring is advised during prolonged therapy to ensure safety and efficacy.